XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statement of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common
Shares Outstanding, Beginning Balance at Dec. 31, 2022   27,440,083      
Stockholders' Equity, Beginning Balance at Dec. 31, 2022 $ 2,070,725 $ 301 $ 352,639 $ 1,835,983 $ (118,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 360,083     360,083  
Stock options exercised, shares   778,358      
Stock options exercised 27,152   (7,858)   35,010
Stock-based compensation expense 7,006   7,006    
Repurchase of common shares, shares   (473,000)      
Repurchase of common shares (40,259)       (40,259)
Deferral of executive and director compensation 1,005   1,005    
Deferred Compensation Arrangement with Individual, Shares Issued   103,081      
Deferred Compensation Arrangement with Individual, Distribution Paid 0   (4,630)   4,630
Shares Outstanding, Ending Balance at Sep. 30, 2023   27,848,522      
Stockholders' Equity, Ending Balance at Sep. 30, 2023 2,425,712 $ 301 348,162 2,196,066 (118,817)
Shares Outstanding, Beginning Balance at Jun. 30, 2023   27,782,616      
Stockholders' Equity, Beginning Balance at Jun. 30, 2023 2,298,459   350,127 2,057,050 (109,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 139,016     139,016  
Stock options exercised, shares   283,292      
Stock options exercised 10,583   (2,559)   13,142
Stock-based compensation expense 2,682   2,682    
Repurchase of common shares, shares   (263,000)      
Repurchase of common shares (25,052)       (25,052)
Deferral of executive and director compensation 24   24    
Deferred Compensation Arrangement with Individual, Shares Issued   45,614      
Deferred Compensation Arrangement with Individual, Distribution Paid     (2,112)   2,112
Shares Outstanding, Ending Balance at Sep. 30, 2023   27,848,522      
Stockholders' Equity, Ending Balance at Sep. 30, 2023 2,425,712 $ 301 348,162 2,196,066 (118,817)
Shares Outstanding, Beginning Balance at Dec. 31, 2023   27,761,299      
Stockholders' Equity, Beginning Balance at Dec. 31, 2023 2,516,939 $ 301 349,907 2,301,348 (134,617)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 430,256     430,256  
Stock options exercised, shares   310,696      
Stock options exercised 13,034   (7,172)   20,206
Stock-based compensation expense 10,859   10,859    
Repurchase of common shares, shares   (922,000)      
Repurchase of common shares (125,819)       (125,819)
Deferral of executive and director compensation 87   87    
Deferred Compensation Arrangement with Individual, Shares Issued   55,059      
Deferred Compensation Arrangement with Individual, Distribution Paid 0   (3,137)   3,137
Shares Outstanding, Ending Balance at Sep. 30, 2024   27,205,054      
Stockholders' Equity, Ending Balance at Sep. 30, 2024 2,845,356 $ 301 350,544 2,731,604 (237,093)
Shares Outstanding, Beginning Balance at Jun. 30, 2024   27,403,908      
Stockholders' Equity, Beginning Balance at Jun. 30, 2024 2,741,117 $ 301 350,554 2,586,155 (195,893)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 145,449     145,449  
Stock options exercised, shares   123,146      
Stock options exercised 5,485   (3,549)   9,034
Stock-based compensation expense $ 3,510   3,510    
Repurchase of common shares, shares 300,000 (322,000)      
Repurchase of common shares $ (50,234)       (50,234)
Deferral of executive and director compensation 29   29    
Deferred Compensation Arrangement with Individual, Shares Issued   0      
Deferred Compensation Arrangement with Individual, Distribution Paid 0   0   0
Shares Outstanding, Ending Balance at Sep. 30, 2024   27,205,054      
Stockholders' Equity, Ending Balance at Sep. 30, 2024 $ 2,845,356 $ 301 $ 350,544 $ 2,731,604 $ (237,093)